InsurTech Fund

The firm concentrates on early-stage companies, including seed, start-up, and pre-IPO rounds. This suggests a strategy of entering early and, where appropriate, supporting portfolio companies with follow-on capital through later private funding rounds before a public listing.

Publicly available information does not list explicit avoidance criteria. However, the firm's name and self-described mandate indicate a singular focus on the insurance technology vertical, making it unlikely to invest in sectors such as general enterprise SaaS, biotech, or consumer internet unless the application sits squarely within the insurance value chain.

Sourcing mechanics are not publicly detailed. Given the firm's location in Pennsylvania, removed from traditional venture hubs, it may cultivate deal flow through relationships with legacy insurance carriers, regional brokers, and industry trade networks rather than through auction processes dominated by coastal venture firms.

The firm identifies as a private equity manager but operates with a venture capital posture, targeting early-stage and pre-IPO companies. This hybrid classification is common in specialist funds that back growth-stage technology businesses without the use of traditional leveraged buyout mechanics.

Disclosed information only references direct early-stage equity investments into insurance technology companies. There is no public record of fund-of-fund commitments or limited partner allocations to outside general partners.